The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population

OBJECTIVE: To determine whether joint destruction, indication for, and response to infliximab in rheumatoid arthritis are associated with the shared epitope (SE) or selected cytokine gene polymorphisms (interleukin (IL) 1B, IL1‐RN, and tumour necrosis α). METHODS: In a large rheumatoid arthritis pop...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Marotte, H, Pallot‐Prades, B, Grange, L, Tebib, J, Gaudin, P, Alexandre, C, Blond, J L, Cazalis, M A, Mougin, B, Miossec, P
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMJ Group 2006
Aiheet:
Extended Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798045/
https://ncbi.nlm.nih.gov/pubmed/16096333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.037150
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC1798045/
https://ncbi.nlm.nih.gov/pubmed/16096333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.037150

Samankaltaisia teoksia